Mbx Biosciences Inc (MBX)

May 31, 2025, 7:24 AM EDT - 6 days ago

MBX Biosciences: Consider Peptide Developer With GLP Drugs As A Speculative Buy

May 20, 2025, 8:00 AM EDT - 17 days ago

MBX Biosciences to Participate in June Investor Conferences

May 12, 2025, 8:00 AM EDT - 25 days ago

MBX Biosciences Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Apr 22, 2025, 8:00 AM EDT - 6 weeks ago

MBX Biosciences to Participate in Citizens and RBC May Investor Conferences

Mar 26, 2025, 8:00 AM EDT - 2 months ago

MBX Biosciences to Participate in the 24th Annual Needham Virtual Healthcare Conference

Mar 17, 2025, 8:00 AM EDT - 2 months ago

MBX Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights

Mar 5, 2025, 8:00 AM EST - 3 months ago

MBX Biosciences Announces Additions to Leadership Team

Mar 3, 2025, 8:00 AM EST - 3 months ago

MBX Biosciences Completes Enrollment in Phase 2 Avail™ Trial of MBX 2109 (Canvuparatide) for Hypoparathyroidism

Feb 18, 2025, 8:00 AM EST - 3 months ago

MBX Biosciences to Participate in March Investor Conferences

Jan 7, 2025, 7:00 AM EST - 5 months ago

MBX Biosciences Announces Positive Phase 1 Topline Results for MBX 1416 for the Treatment of Post-bariatric Hypoglycemia

Nov 18, 2024, 8:00 AM EST - 7 months ago

MBX Biosciences Announces Last Subject Last Visit in Phase 1 Trial of MBX 1416 for the Treatment of Post-Bariatric Hypoglycemia

Oct 28, 2024, 8:00 AM EDT - 7 months ago

MBX Biosciences to Participate in Upcoming November Investor Conferences

Sep 30, 2024, 8:00 AM EDT - 8 months ago

MBX Biosciences Presents MBX 2109 Phase 2 Avail™ Hypoparathyroidism Trial Rationale and Design at the ASBMR 2024 Annual Meeting

Sep 16, 2024, 4:05 PM EDT - 9 months ago

MBX Biosciences Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Sep 14, 2024, 5:00 AM EDT - 9 months ago

U.S. IPO Weekly Recap: 3 Biotechs Lead Active September IPO Market

BCAX GLXG TDTH XCH ZBIO

Sep 13, 2024, 12:36 PM EDT - 9 months ago

MBX Biosciences shares surge 44% in blockbuster Nasdaq debut

Sep 12, 2024, 7:20 PM EDT - 9 months ago

MBX Biosciences raises $163.2 mln in US IPO

Sep 12, 2024, 7:11 PM EDT - 9 months ago

MBX Biosciences Announces Pricing of Initial Public Offering

Sep 9, 2024, 6:30 AM EDT - 9 months ago

MBX Biosciences Announces Launch of Initial Public Offering

Aug 23, 2024, 4:44 PM EDT - 10 months ago

MBX Biosciences IPO Registration Document (S-1)